During the five-year span from 2013 to 2018, a surge of interest amongst researches was noted in unveiling novel therapeutic targets and delving deeper into the pathophysiological intricacies of atherosclerosis via the examination of “ppar gamma”, “nf-kappa b”, and “hydrogen peroxide”. This evidence concerns the gene PPARG and atherosclerosis.